Facebook Pixel
IMID Rheumatology

Discussing AxSpA: Episode 4

IMID Rheumatology
IMID Rheumatology
Join Professor Xenofon Baraliakos and Dr Sofia Ramiro as they discuss the latest top research in axSpA. In this edition, our Steering Committee members discuss two of the latest papers in the field of axSpA therapeutics, providing their own insights and experience into two very interesting publications. The first of our publications details the 2022 ASAS-EULAR recommendations for the management of axial spondyloarthritis. The second of today’s papers explores the efficacy and safety of bDMARDs in axSpA managment.
Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.
IMID Rheumatology
Not playing